{"version":"1.0","type":"link","title":"Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC - A Delphi study by the Asian Thoracic Oncology Research Group (ATORG).","author_name":"Tan AC 외","author_url":"https://prs-insight.online/author/Tan%20AC","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95253","thumbnail_width":1200,"thumbnail_height":630}